SCHEMBL6421629

SCHEMBL6421629

O=c1cccc2nc3nc4c(ccc5occcc54)cc3nc12

nearest known ligand 0.33

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
FTO Q9C0B1 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
ELANE P08246 1/20 0.32
HPGD P15428 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
DYRK1A Q13627 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL118020 0.72 MAOA (0.40) MAOAMAOBFTOKDM4EALDH1A1
SCHEMBL3295735 0.71 ALDH1A1 (0.37) MAOAMAOBFTOKDM4EALDH1A1
SCHEMBL6421632 0.70 MAOB (0.35) MAOAMAOBFTODYRK1A
SCHEMBL6708105 0.67 ALDH1A1 (0.43) MAOAMAOBFTOKDM4EALDH1A1
SCHEMBL10746966 0.66 KDM4E (0.40) KDM4EALDH1A1HPGD
SCHEMBL5229303 0.66 KDM4E (0.40) MAOAMAOBFTOKDM4EALDH1A1
SCHEMBL29588824 0.66 MAPK10 (0.42) MAOAMAOBFTOKDM4EALDH1A1
SCHEMBL4495841 0.66 MAPK10 (0.42) MAOAMAOBFTOKDM4EALDH1A1
SCHEMBL28747394 0.65 RCE1 (0.35) MAOAMAOBFTOKDM4EALDH1A1
SCHEMBL6350173 0.63 KDM4E (0.41) KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1297556-C New benzo[b]chromeno-naphthyridin-7-one and pyrano[2',3':7,8] quino[2,3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2007-01-31 CN disclosed
EP-1561753-A2 Benzo[b]chromenonapthyridin-7-one and pyrano[2',3':7,8]quino[2,3-b]Quinoxalin-7-one derivatives, process of synthesis, pharmaceutical compositions and their antitumoral properties for the treatment of cancer Les Laboratoires Servier (FR) 2005-08-10 EP disclosed